Busse R, Bassenge E
Z Kardiol. 1984 Aug;73(8):477-91.
The cyclic interactions between myosin cross bridges and the actin filament in the presence of Ca++ with a sliding of both filaments passed each other, is considered also in vascular smooth muscle as the basic contractile mechanism. While in the striated muscle the regulation of the actin-myosin interaction occurs at the level of the actin filaments, there is a growing body of evidence that the contractile activation of the vascular smooth muscle is primarily regulated by phosphorylation of the 20,000-Dalton myosin light chain. This reaction is catalyzed by a calcium-calmodulin-dependent myosin light chain kinase. Additionally, dephosphorylated myosin cross bridges which remain attached to actin filaments over prolonged periods of time ("latch bridges") at low myoplasmic Ca2+-concentrations seem to be involved in the vascular smooth muscle in maintaining tonic active stress at a very low energy expenditure. In most arterial smooth muscle cells, the initiation of contraction (electromechanical coupling) is not associated with action potentials, but is coupled with graded membrane depolarization. During the process of excitation-contraction coupling, two mechanisms lead to increased myoplasmic calcium: a) Calcium influx through voltage-dependent channels along an electro-chemical gradient. b) Release of calcium from the sarcoplasmic reticulum or from the inside of the cell membrane, triggered either by calcium influx or directly by membrane depolarization. The pharmaco-mechanical coupling, i.e., the contractile activation by drugs without depolarization as initiating step, seems to be realized only in a few specific vessels. The stimulation of the phosphatidyl-inositol turnover (PI-cycle) in the plasma membrane by activation of alpha 1-adrenergic receptors can also be demonstrated in vascular smooth muscle cells. However, whether or not this PI-response plays a primary role in the increase of myoplasmic Ca2+ remains to be settled. The activation of alpha 2-adrenergic receptors seems to involve the action of an inhibitory guanine nucleotide-binding protein on the catalytic moiety of the adenylate cyclase. Thus, the contractile response observed may be attributed to the decrease of cyclic AMP (which is responsible for dilating effects via phosphorylation of various regulatory proteins). The decrease in the myoplasmic concentration of free-ionized calcium as a basic principle of relaxation comes about by different mechanisms, which can be classified as follows: a) Inhibition of transmembrane calcium influx into vascular smooth muscle cells by Ca-antagonists, which specifically interfere with plasmalemmal Ca2+-channels.(ABSTRACT TRUNCATED AT 400 WORDS)
在钙离子存在的情况下,肌球蛋白横桥与肌动蛋白丝之间的循环相互作用以及两根丝的相互滑动,在血管平滑肌中也被视为基本的收缩机制。在横纹肌中,肌动蛋白 - 肌球蛋白相互作用的调节发生在肌动蛋白丝水平,然而,越来越多的证据表明,血管平滑肌的收缩激活主要由20,000道尔顿肌球蛋白轻链的磷酸化调节。该反应由钙 - 钙调蛋白依赖性肌球蛋白轻链激酶催化。此外,在低肌浆钙浓度下长时间附着于肌动蛋白丝的去磷酸化肌球蛋白横桥(“闩锁桥”)似乎参与了血管平滑肌以极低能量消耗维持紧张性主动张力的过程。在大多数动脉平滑肌细胞中,收缩的起始(电 - 机械偶联)与动作电位无关,而是与分级膜去极化偶联。在兴奋 - 收缩偶联过程中,有两种机制导致肌浆钙增加:a)钙通过电压依赖性通道沿电化学梯度内流。b)钙从肌浆网或细胞膜内释放,由钙内流或直接由膜去极化触发。药物 - 机械偶联,即药物在无去极化作为起始步骤的情况下引发收缩激活,似乎仅在少数特定血管中实现。通过激活α1 - 肾上腺素能受体刺激质膜中的磷脂酰肌醇周转(PI循环)在血管平滑肌细胞中也能得到证实。然而,这种PI反应是否在肌浆钙增加中起主要作用仍有待确定。α2 - 肾上腺素能受体的激活似乎涉及抑制性鸟嘌呤核苷酸结合蛋白对腺苷酸环化酶催化部分的作用。因此,观察到的收缩反应可能归因于环磷酸腺苷的减少(环磷酸腺苷通过各种调节蛋白的磷酸化产生舒张作用)。作为舒张基本原则的肌浆游离离子钙浓度降低是由不同机制引起的,可分类如下:a)钙拮抗剂抑制钙跨膜流入血管平滑肌细胞,钙拮抗剂特异性干扰质膜钙通道。(摘要截断于400字)